References
- Alayash AI. 2014. Blood Substitutes: why haven’t we been more successful? Trends Biotechnol. 32:177–185.
- Allen CJ, Tashiro J, Valle EJ, Thorson CM, Shariatmadar S, Schulman CI, et al. 2014. Initial hematocrit predicts the use of blood transfusion in the pediatric trauma patient. J Pediatr Surg. 49:1678–1682.
- Atyabi N, Yasini SP, Jalali SM, Shaygan H. 2012. Antioxidant effect of different vitamins on methemoglobin production: an in vitro study. Vet Res Forum. 3:97–101.
- Bian Y, Chang TM. 2015. A novel nanobiotherapeutic poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] with no cardiac toxicity for the resuscitation of a rat model with 90 minutes of sustained severe hemorrhagic shock with loss of 2/3 blood volume. Artif Cells Nanomed Biotechnol. 43:1–9.
- Bian Y, Rong Z, Chang TM. 2012. Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant. Artif Cells Nanomed Biotechnol. 39:127–136.
- Buehler PW, D’Agnillo F, Schaer DJ. 2010. Hemoglobin-based oxygen carrier: from mechanisms of toxicity and clearance to rational drug design. Trends Mol Med. 16:447–457.
- Chen JY, Scerbo M, Kramer G. 2009. A review of blood substitutes: examining the history, clinical trial results, and ethics of hemoglobin-based oxygen carriers. Clinics. 64:803–813.
- Evelyn KA, Malloy HT. 1938. Microdetermination of oxyhemoglobin, methemoglobin, and sulfhemoglobin in single of blood. Biol Chem. 126:655–662.
- Greenburg AG. 2009. The ideal blood substitute. Crit Care Clin. 25:415–424.
- Fontes P, Lopez R, Plaats A, Vodovotz Y, Minervini M, Scott V. 2014. Liver preservation with machine perfusion and a newly developed cell-free oxygen carrier solution under subnormothermic conditions. Am J Transplant. 15:381–394.
- Fronticelli C, Koehler RC. 2009. Design of recombinant hemoglobin for use in transfusion fluids. Crit Care Clin. 25:357–371.
- Jahr JS, Walker V, Manoochehri K. 2007. Blood substitutes as pharmacotherapies in clinical practice. Curr Opin Anaesthesiol. 20:325–330.
- Jain AK, Mehra NK, Swarnakar NK. 2015. Role of antioxidant for the treatment of cardiovascular diseases: challenges and opportunities. Curr Pharm Des. 21:1–15.
- Karamian R, Komaki A, Salehi I, Tahmasebi L, Komaki H, Shahidi S, Sarihi A. 2015. Vitamin C reversed lead-induced deficits in hippocampal synaptic plasticity in rats. Brain Res Bull. 116:7–15.
- Kleinhans H, Mann O, Schurr PG, Kaifi JT, Hansen B, Izbicki JR, Strate T. 2006. Oxygen radical formation does not have an impact in the treatment of severe acute experimental pancreatitis using free cellular hemoglobin. World J Gastroenterol. 12:2914–2918.
- Li T, Zhang Z, Liao D, Chen Y, Yang C, Xu X, Liu J. 2012. The effect of polymerized placenta hemoglobin on renal ischemia/reperfusion injury. Artif Cells Nanomed Biotechnol. 40:396–399.
- Ortiz D, Barros M, Yan S, Cabrales P. 2014. Resuscitation from hemorrhagic shock using polymerized hemoglobin compared to blood. Am J Emerg Med. 32:248–255.
- Rempf C, Standl T, Schenke K, Chammas K, Gottschalk A, Burmeister MA, Gottschalk A. 2014. Administration of bovine polymerized haemoglobin before and during coronary occlusion reduces infarct size in rabbits. Br J Anaesth. 103:496–504.
- Silverman TA, Weiskopf RB. 2009. Hemoglobin-based oxygen carriers: current status and future directions. Transfusion. 49:2495–2515.
- Su X, Guo S, Huang X, Wang X, Qi D, Yang C. 2014. Control of oxidative reactions of hemoglobin in the design of blood substitutes: role of the Vc, NAC, TEMPO and their reductant system. Artif Cells Nanomed Biotechnol. 42:222–228.
- Vermeijden WJ, Klarenbosch JV, Gu YJ, Mariani MA, Buhre WF, Scheeren TL, et al. 2015. Effects of cell-saving devices and filters on transfusion in cardiac surgery: a multicenter randomized study. Ann Thorac Surg. 99:26–32.